Imbruvica
List of products in the National Drug Code with proprietary name imbruvica. This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
57962-007 | Imbruvica | Ibrutinib | Suspension | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-014 | Imbruvica | Ibrutinib | Tablet, Film Coated | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-070 | Imbruvica | Ibrutinib | Capsule | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-140 | Imbruvica | Ibrutinib | Capsule | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-280 | Imbruvica | Ibrutinib | Tablet, Film Coated | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-420 | Imbruvica | Ibrutinib | Tablet, Film Coated | Oral | Pharmacyclics Llc | Human Prescription Drug |
57962-560 | Imbruvica | Ibrutinib | Tablet, Film Coated | Oral | Pharmacyclics Llc | Human Prescription Drug |